Aprogen, Inc Logo

Aprogen, Inc

Develops and manufactures biologic medicines, including biosimilars and novel drugs.

007460 | KO

Overview

Corporate Details

ISIN(s):
KR7007460009
LEI:
Country:
South Korea
Address:
경기도 성남시 중원구 둔촌대로 545 경기도 성남시 중원구 둔촌대로545, 비1층 (상대원동, 한라시그마밸리), 성남시

Description

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2019-04-19 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.1 KB
2019-04-19 00:00
최대주주등소유주식변동신고서
Korean 79.7 KB
2019-04-10 00:00
주식등의대량보유상황보고서(약식)
Korean 61.7 KB
2019-04-05 00:00
조회공시요구(현저한시황변동)에대한답변(중요공시대상없음)
Korean 6.9 KB
2019-04-04 00:00
조회공시요구(현저한시황변동)
Korean 3.7 KB
2019-04-04 00:00
주권관련사채권의취득결정
Korean 31.5 KB
2019-04-02 00:00
주식등의대량보유상황보고서(일반)
Korean 69.7 KB
2019-04-01 00:00
사업보고서 (2018.12)
Korean 479.2 KB
2019-03-29 00:00
정기주주총회결과
Korean 24.1 KB
2019-03-29 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 6.3 KB
2019-03-29 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 6.2 KB
2019-03-26 00:00
주식등의대량보유상황보고서(약식)
Korean 54.5 KB
2019-03-26 00:00
주식등의대량보유상황보고서(일반)
Korean 70.1 KB
2019-03-22 00:00
주식등의대량보유상황보고서(약식)
Korean 77.9 KB
2019-03-21 00:00
감사보고서제출
Korean 21.9 KB

Automate Your Workflow. Get a real-time feed of all Aprogen, Inc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Aprogen, Inc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Aprogen, Inc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.